Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
In this episode, Josh Long, legal and regulatory editor, and Rachel Adams, managing editor, discuss: dismissal of a wrongful death lawsuit against USPlabs; DMAA’s availability in the market, despite FDA’s stance on the ingredient; and criminal indictment of USPlabs by federal government.
A wrongful death lawsuit filed against USPlabs LLC, GNC Corp., affiliated entities, and USPlabs’ executives Jonathan Vincent Doyle and Jacob Geissler was “dismissed with prejudice” last week after a federal judge upheld a ruling that struck the testimony of three of plaintiffs’ experts. The experts wanted to show the dangers of the ingredient DMAA (dimethylamylamine) in UPSlabs’ Jack3d preworkout supplement, and that it was likely a contributing factor in the soldier’s death.
In this episode, Josh Long, legal and regulatory editor, and Rachel Adams, managing editor, discuss:
Dismissal of a wrongful death lawsuit against USPlabs;
DMAA’s availability in the market, despite FDA’s stance on the ingredient; and
Criminal indictment of USPlabs by federal government.
Links and Resources:
As Jury Trial Approaches, USPlabs Says DMAA Supplement Didn’t Cause Soldier’s Death
Got feedback? Email Josh at [email protected] or Rachel at [email protected], or tweet to @NatProdINSIDER using the hashtag #INSIDERpodcast
About the Author(s)
You May Also Like
Recommended
.png?width=800&auto=webp&quality=80&disable=upscale)